VERSAPAP DEVICE

The VersaPAP® device was developed to provide clinicians with a single, simplified way to deliver positive airway pressure therapy. The integrated manometer provides immediate feedback and makes it easy to monitor for desired airway pressures of 6 to 32 cm H2O (@5 – 15 L/min flow).

All patients have the chance of developing some form of atelectasis post-surgically, but most will recover uneventfully.1 Atelectasis contributes to postoperative pulmonary complications which are common, serious and costly.1 The addition of Positive Airway Pressure (PAP) can help reduce or reverse partial or complete collapse of the lung.2 For patients who are at higher risk of developing atelectasis, incentive spirometry alone may not be enough.3

Download the VERSAPAP® DEVICE sell sheet.

REFERENCES
1. RD Restrepo, Braverman J. Current challenges in the recognition, prevention and treatment of perioperative pulmonary atelectasis. Expert Rev Respir Med 2015;9(1):97-107.
2. AARC Clinical Practice Guideline: Use of Positive Airway Pressure Adjuncts to Bronchial Hygiene Therapy. Respir Care 1993;38(5):516–521.
3. RD Restrepo, Wettstein R, Wittnebel L, Tracy M. AARC Clinical Practice Guideline. Incentive Spirometry: 2011. Respir Care 2011;56(10):1600-1604.